PMID- 17068816 OWN - NLM STAT- MEDLINE DCOM- 20070227 LR - 20211203 IS - 0736-0266 (Print) IS - 0736-0266 (Linking) VI - 25 IP - 2 DP - 2007 Feb TI - Molecular effects of sodium hyaluronate on the healing of avian supracoracoid tendon tear: according to in situ hybridization and real-time polymerase chain reaction. PG - 173-84 AB - Hyluronic acid (HA) on tissue healing has been controversial. We examined the molecular pharmacology of HA injection at the suture site in an acute model of supracoracoid tendon laceration using chickens, an injury of a nonweight-bearing joint considered similar to the human shoulder. Expression of mRNAs encoding alpha I (I) and alphaI (III) procollagens was localized using in situ hybridization (ISH). Intensities of mRNA expression for alpha I (I) and alpha I (III) procollagens, transforming growth factor-beta1 (TGF- beta1), basic fibroblast growth factor (bFGF), and insulin-like growth factor (IGF) were determined by quantitative reverse transcription-polymerase chain reaction (RT-PCR). Histologically, chickens with HA injection (HA group) showed early restoration of continuity at the laceration site than saline-injection controls (saline-injection group). By ISH, the expression rate of cells at the lesion site that contained alpha I (I) and alpha I (III) procollagen mRNAs were somewhat higher in the HA group than in the saline-injection group. By RT-PCR, the HA- and saline-injection groups showed no significant difference in expression of alpha I (I) and alpha I (III) procollagen mRNA between weeks 1 and 6. The saline -injection group exhibited significant decrease in TGF-beta1 expression between weeks 1 and 3, and in bFGF expression between weeks 1 and 2; however, the HA group showed no such decrease. As for IGF, no difference was appreciable in both groups between weeks 1 and 6. A single injection of HA could cause earlier restoration of continuity at the lacerated site of the supracoracoid tendon. FAU - Shimpuku, Eiji AU - Shimpuku E AD - Department of Orthopaedic Surgery, Surgical Science, Tokai University School of Medicine, Bohseidai, Isehara, Kanagawa 259-1193, Japan. cbt58420@pop21.odn.ne.jp FAU - Hamada, Kazutoshi AU - Hamada K FAU - Handa, Akiyoshi AU - Handa A FAU - Kobayashi, Kunihiko AU - Kobayashi K FAU - Nakajima, Tomotaka AU - Nakajima T FAU - Yamazaki, Hitoshi AU - Yamazaki H FAU - Nakamura, Masato AU - Nakamura M FAU - Fukuda, Hiroaki AU - Fukuda H FAU - Mochida, Joji AU - Mochida J LA - eng PT - Journal Article PL - United States TA - J Orthop Res JT - Journal of orthopaedic research : official publication of the Orthopaedic Research Society JID - 8404726 RN - 0 (Adjuvants, Immunologic) RN - 0 (Collagen Type I) RN - 0 (Collagen Type I, alpha 1 Chain) RN - 0 (RNA, Messenger) RN - 0 (Somatomedins) RN - 0 (Transforming Growth Factor beta1) RN - 103107-01-3 (Fibroblast Growth Factor 2) RN - 451W47IQ8X (Sodium Chloride) RN - 9004-61-9 (Hyaluronic Acid) SB - IM MH - Adjuvants, Immunologic/*pharmacology MH - Animals MH - Chickens MH - Collagen Type I/genetics/metabolism MH - Collagen Type I, alpha 1 Chain MH - Female MH - Fibroblast Growth Factor 2/genetics/metabolism MH - Gene Expression Regulation/drug effects MH - Hyaluronic Acid/*pharmacology MH - In Situ Hybridization MH - RNA, Messenger/genetics/metabolism MH - Reverse Transcriptase Polymerase Chain Reaction MH - Sodium Chloride/pharmacology MH - Somatomedins/genetics/metabolism MH - Tendon Injuries/drug therapy/*pathology/physiopathology MH - Tendons/*drug effects/pathology/physiopathology MH - Transforming Growth Factor beta1/genetics/metabolism MH - Wound Healing/*drug effects/physiology EDAT- 2006/10/28 09:00 MHDA- 2007/02/28 09:00 CRDT- 2006/10/28 09:00 PHST- 2006/10/28 09:00 [pubmed] PHST- 2007/02/28 09:00 [medline] PHST- 2006/10/28 09:00 [entrez] AID - 10.1002/jor.20277 [doi] PST - ppublish SO - J Orthop Res. 2007 Feb;25(2):173-84. doi: 10.1002/jor.20277.